VOYXACT FDA approval date

The FDA approved VOYXACT on 25 Nov 2025.

FDA approval date
25 Nov 2025

Drug identity has not yet been verified against registry records

Also recorded as SIBEPRENLIMAB-SZSI

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2025-11-25DayVOYXACTFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761434", "applicant_as_listed_by_fda": "OTSUKA PHARM CO LTD", "brand_names": ["VOYXACT"], "active_ingredients": ["SIBEPRENLIMAB-SZSI"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20251125", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026